Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
This is a multi-center, Prospective, observational study，to evaluate the safety and influencing factors of albumin-bound paclitaxel in the real-world chinese population，and evaluate of the efficacy of albumin-bound paclitaxel in patients with malignant tumors and its impact on quality of life.
Cancer
OTHER: Observational study
Percentage and severity of Participants With Adverse Events (AEs), percentage and CTC AE(v5.0) of AEs, 28 days after the end of the last chemotherapy cycle
Objective response rate (ORR) Assessed Using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1), ORR is defined as the rate of CR or PR, as determined by IRC using RECIST v1.1 criteria., From signing informed consent，assessed up to end of study (up to approximately 24months)|evaluate patients' quality of life by the European Cancer Research and Treatment Tissue Cancer Quality Core Questionnaire EORTCQLQ-C30, EORTC QLQC30 scale was used to score the quality of life before treatment, at each chemotherapy cycle, and at the end of treatment., From signing informed consent，assessed up to end of study (up to approximately 24months)
This is a multi-center, Prospective, observational study，to evaluate the safety and influencing factors of albumin-bound paclitaxel in the real-world chinese population，and evaluate of the efficacy of albumin-bound paclitaxel in patients with malignant tumors and its impact on quality of life.